Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Neuberger Berman Municipal Fund	NBH	25. nov 2024	10.75	+0.75
Neuberger Berman Next Generation Connectivity Fund	NBXG	25. nov 2024	13.13	+0.23
Neuberger Berman Real Estate Securities Income Fund	NRO	25. nov 2024	3.86	+1.05
NeueHealth	NEUE	25. nov 2024	4.86	-2.80
Neumora Therapeutics	NMRA	25. nov 2024	9.67	-0.72
Neuraxis	NRXS	25. nov 2024	3.03	-0.66
Neurobo Pharmaceuticals	NRBO	25. nov 2024	2.42	+2.11
Neurocrine Biosciences	NBIX	25. nov 2024	127.11	+1.16
Neurogene	NGNE	25. nov 2024	22.32	+9.93
NeuroMetrix	NURO	25. nov 2024	4.22	-0.71
Neuronetics	STIM	25. nov 2024	0.97	+9.62
NeuroOne	NMTC	25. nov 2024	0.61	-10.01
Neuropace	NPCE	25. nov 2024	10.66	+9.90
NeuroSense Therapeutics	NRSN	25. nov 2024	0.88	-2.51
Nevro	NVRO	25. nov 2024	4.55	+0.66
New America High Income Fund	HYB	25. nov 2024	8.22	-0.60
New Concept Energy	GBR	25. nov 2024	1.18	-3.28
New England Realty Associates LP Unit A	NEN	25. nov 2024	82.49	0.00
New Fortress Energy A	NFE	25. nov 2024	9.71	-0.41
New Found Gold	NFGC	25. nov 2024	1.65	+0.61
New Germany Fund	GF	25. nov 2024	8.02	+0.63
New Gold	NGD	25. nov 2024	2.66	-6.01
New Horizon Aircraft	HOVR	25. nov 2024	0.51	+7.28
New Mountain Finance Corp	NMFC	25. nov 2024	11.80	+0.34
New Oriental Education & Technology Group ADR	EDU	25. nov 2024	58.79	+2.49
New Pacific Metals	NEWP	25. nov 2024	1.57	-1.26
New Providence Acquisition II A	NPAB	25. nov 2024	11.30	0.00
New Providence Acquisition II Unit	NPABU	25. nov 2024	12.20	0.00
New Residential Investment A Pref	RITM-A	25. nov 2024	25.47	+0.16
New Residential Investment B Pref	RITM-B	25. nov 2024	25.31	+0.05

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.